Sign in

CIK 0001896212 · <br>Emerging growth company

CDT Equity Inc.

Sign in to watch
Ticker
CDT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
873272543
Phone
(646) 491 9132
Business address
4851 TAMIAMI TRAIL NORTH, SUITE 200, NAPLES, FL, 34103
Former names
CONDUIT PHARMACEUTICALS INC., Murphy Canyon Acquisition Corp.

Securities

  • CDT Common Stock Nasdaq
  • CDTTW Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 2 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-10-23 Regan Andrew 10% owner Other acquisition +499,616 499,618
2026-10-22 Regan Andrew 10% owner Other acquisition +1,347,616 1,347,619
2026-08-28 Regan Andrew Chief Executive Officer Other acquisition +543,683 569,322
2026-08-28 Regan Andrew Chief Executive Officer Sale −29 569,322
2026-08-28 Regan Andrew Chief Executive Officer Option exercise · Pre-Funded Warrants −543,683 $0.00 $54 0
2026-08-28 Regan Andrew Chief Executive Officer Other acquisition +5,436,830 5,693,223
2026-08-28 Regan Andrew Chief Executive Officer Sale −290 5,692,933
2026-08-28 Regan Andrew Chief Executive Officer Option exercise · Pre-Funded Warrants −5,436,830 $0.00 $544 0
2026-07-30 Regan Andrew Chief Executive Officer Other acquisition · Pre-Funded Warrants +5,436,830 $0.00 $544 543,683
2026-07-30 Regan Andrew Chief Executive Officer Other acquisition · Pre-Funded Warrants +5,436,830 $0.00 $544 5,436,830
2026-06-18 Taylor Mark Andrew 10% owner Sale −5,000 $0.71 $4K 1,464,711
2026-06-18 Taylor Mark Andrew 10% owner Sale −1,464,711 $1.44 $2.1M 0
2026-06-18 Taylor Mark Andrew 10% owner Sale −5,000 $0.75 $4K 593,289
2026-06-18 Taylor Mark Andrew 10% owner Sale −593,289 $1.40 $829K 0
2026-05-13 Regan Andrew Chief Executive Officer Grant or award +100,000 $1.90 $190K 256,393
2026-03-24 Regan Andrew Chief Executive Officer Grant or award +147,401 156,393
2026-03-24 Regan Andrew Chief Executive Officer Conversion · Pre-Funded Warrants −147,401 $0.00 $15 0
2026-03-17 Taylor Mark Andrew 10% owner Other acquisition +51,420,358 51,700,014
2026-03-17 Taylor Mark Andrew 10% owner Other disposition · Pre-Funded Warrants −51,161,318 0
2026-02-19 Taylor Mark Andrew 10% owner Other disposition −46,902 279,656

Page 1 of 5 · 90 trades